TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sanofi-Aventis Norge AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
531,040
|
498,097
|
487,434 |
| Financial expenses |
2,979
|
865
|
925 |
| Earnings before taxes |
30,688
|
27,847
|
42,070 |
| Total assets |
226,080
|
233,296
|
281,739 |
| Current assets |
224,028
|
231,603
|
279,938 |
| Current liabilities |
216,708
|
229,800
|
245,748 |
| Equity capital |
9,371
|
3,496
|
35,990 |
| - share capital |
1,146
|
1,207
|
1,286 |
| Employees (average) | 64 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
4.1%
|
1.5%
|
12.8% |
| Turnover per employee | 8,298 | ||
| Profit as a percentage of turnover |
5.8%
|
5.6%
|
8.6% |
| Return on assets (ROA) |
14.9%
|
12.3%
|
15.3% |
| Current ratio |
103.4%
|
100.8%
|
113.9% |
| Return on equity (ROE) |
327.5%
|
796.5%
|
116.9% |
| Change turnover |
57,949
|
40,614
|
-31,533 |
| Change turnover % |
12%
|
9%
|
-6% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.